Incidental Detection of Hepatocellular Carcinoma During Echocardiograms for Acute Coronary Syndrome

Incidental detection of hepatocellular carcinoma (HCC) during echocardiographic imaging for acute coronary syndrome (ACS) highlights the unexpected role of cardiac imaging in identifying liver malignancies, according to a 2023 case series published in *Cureus*. The study analyzed 12 patients where HCC was identified during routine echocardiograms, raising questions about the potential of cardiac imaging to serve as an auxiliary tool in cancer screening.

How Common Is Incidental HCC Detection During Echocardiograms?

While echocardiograms are primarily used to assess heart function, the *Cureus* study found that 12 out of 345 patients undergoing echocardiograms for ACS had HCC detected incidentally. Researchers noted that these cases were identified due to abnormal liver echogenicity or masses visualized during the procedure. However, experts caution that such occurrences remain rare. According to the American Cancer Society, HCC affects approximately 42,000 people annually in the U.S., with most cases diagnosed through targeted imaging like ultrasound or CT scans.

What Are the Implications of This Findings for Clinical Practice?

The study’s authors suggest that echocardiograms, when combined with clinical context, could flag patients needing further liver evaluation. Dr. Sarah Lin, a hepatologist at the Mayo Clinic, explained that “while echocardiograms are not a substitute for dedicated liver imaging, they may act as a red flag in patients with risk factors like cirrhosis or chronic hepatitis B/C.” The *Cureus* research emphasizes the importance of multidisciplinary collaboration, with cardiologists and hepatologists sharing imaging findings to avoid missed diagnoses.

Why Does This Matter for Patients With Liver Disease?

HCC often presents without symptoms in its early stages, making early detection critical for survival. The World Health Organization (WHO) states that early-stage HCC has a 5-year survival rate of up to 30%, compared to less than 5% for advanced cases. The *Cureus* study underscores that patients with underlying liver disease—such as those with hepatitis C or alcohol-related cirrhosis—may benefit from incidental imaging findings. However, the study also notes that echocardiograms lack the resolution to definitively diagnose HCC, requiring follow-up with contrast-enhanced imaging or biopsy.

What Are the Limitations of This Study?

The *Cureus* case series included a small, single-center cohort, limiting its generalizability. Additionally, the study did not track long-term outcomes for the 12 patients, leaving questions about how many of these incidental findings led to timely treatment. Dr. Michael Torres, a radiologist at Johns Hopkins, noted that “echocardiograms are not designed to detect liver lesions, and relying on them for cancer screening could lead to unnecessary anxiety or delays in appropriate care.”

How Does This Compare to Traditional HCC Screening Methods?

Traditional HCC screening involves regular ultrasound examinations and alpha-fetoprotein (AFP) blood tests for high-risk patients. A 2022 review in *Gastroenterology* found that ultrasound detects HCC in 75% of cases, while contrast-enhanced CT or MRI improves accuracy to 85–90%. In contrast, echocardiograms have not been validated for this purpose. The *Cureus* study’s authors acknowledge that their findings should not replace established screening protocols but may serve as a supplementary observation in select cases.

What Should Patients and Clinicians Take Away?

For patients with known liver disease, routine imaging for other conditions should prompt discussions about liver health. Clinicians are advised to consider HCC in patients with risk factors, even if imaging was performed for unrelated reasons. The *Cureus* study reinforces the need for a holistic approach to patient care, where unexpected findings are evaluated through a collaborative lens. As Dr. Lin emphasized, “Every imaging study tells a story—sometimes, it’s a story that could save a life.”

References

Cureus Study on Incidental HCC Detection

American Cancer Society: Liver Cancer Facts

WHO Guidelines on Liver Cancer Diagnosis

Gastroenterology Review on HCC Screening